프리시젼바이오 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 민준홍, was filed 10 Feb 2026.
프리시젼바이오: what insiders have been doing
This page follows insider dealings at 프리시젼바이오 as filed with DART (FSS), a company from the Health Care sector. Over the twelve months to 8 November 2026, 4 filings were filed, from 3 insiders.
Only purchases show up on the open market, 4 purchases in all, filed by 3 insiders. No amount is published for 4 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 2 senior executives.
The last purchase on record was published on 10 February 2026, which is 273 days ago.
For context, the typical company on the same exchange (median of 2,657 companies) published 7 filings over the same period, against 4 filings here. Our records for 프리시젼바이오 go back to 2021, with 15 purchases and 3 sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 978,019 sharesShareKRXDART:20260210000694Canonical exit: 11 May 2026 (T+90)
- 1,197,269 sharesShareKRXDART:20260209000672Canonical exit: 10 May 2026 (T+90)
- 1,197,269 sharesKRXDART:20260209000660Canonical exit: 5 May 2026 (T+90)
- 380,976 sharesShareKRXDART:20260206001853Canonical exit: 7 May 2026 (T+90)
- 6,343,284 sharesKRXDART:20251106000373Canonical exit: 2 Feb 2026 (T+90)
- 6,343,284 sharesShareKRXDART:20251106000380Canonical exit: 4 Feb 2026 (T+90)
- ShareKRXDART:20241010000581Canonical exit: 31 Dec 2024 (T+90)
- 0KRXDART:20241010000567
- 2,905,545 sharesKRXDART:20241007000090
- ShareKRXDART:20241007000094
- ●Executives0DART
- 282,908 sharesKRXDART:20240910000666
- ShareKRXDART:20240830001832
- 0KRXDART:20240710000604
- 3,449,732 sharesKRXDART:20240705000420Canonical exit: 30 Sept 2024 (T+90)
- 3,449,732 sharesKRXDART:20231121000243Canonical exit: 18 Feb 2024 (T+90)
- ShareKRXDART:20230627000355
- 3,449,732 sharesKRXDART:20220613000118Canonical exit: 11 Sept 2022 (T+90)
- 25,500 shares@ ₩5,000.00100.0% of flowShareKRXDART:20220324000588Canonical exit: 16 Jun 2022 (T+90)
- 15,000 shares@ ₩5,000.00100.0% of flowShareKRXDART:20220324000598Canonical exit: 16 Jun 2022 (T+90)
- 40,614 shares@ ₩5,198.9462100.0% of flowShareKRXDART:20220324000580Canonical exit: 16 Jun 2022 (T+90)
- 16,000 shares@ ₩6,010.00100.0% of flowShareKRXDART:20220324000612Canonical exit: 16 Jun 2022 (T+90)
- 36,000 shares@ ₩6,010.00100.0% of flowShareKRXDART:20220324000607Canonical exit: 16 Jun 2022 (T+90)
- ●Executives0DART
- ShareKRXDART:20211216000349
25 of 32 declarations
About 프리시젼바이오
Precision Bio is a company listed on XKRX that provides innovative solutions in the life sciences and diagnostics sectors.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
